GenePath

GenePath

Share

A Genetic counselling and pathology initiatives

23/09/2026

We are proud to collaborate with 𝐍𝐚đĨ𝐚 𝐆𝐞𝐧𝐞𝐭đĸ𝐜đŦ as country (Bangladesh) partner. âŖ
âŖ
Genetics Essential Training Series 2026 - Session 6âŖ
âŖ
𝐁𝐞𝐲𝐨𝐧𝐝 𝐁𝐑𝐂𝐀: 𝐆𝐞đĢđĻđĨđĸ𝐧𝐞 𝐓𝐞đŦ𝐭đĸ𝐧𝐠 đĸ𝐧 𝐇𝐞đĢ𝐞𝐝đĸ𝐭𝐚đĢ𝐲 𝐁đĢ𝐞𝐚đŦ𝐭 𝐚𝐧𝐝 đŽđ¯đšđĢđĸ𝐚𝐧 𝐂𝐚𝐧𝐜𝐞đĢâŖ
âŖ
đŸŽ™ī¸ Dr. Ervina Kimberly — Medical Affairs, NalaGeneticsâŖ
đŸŽ™ī¸ Dr. Syeda Zubeda — Medical Geneticist, Strand Life SciencesâŖ
âŖ
đŸ—Ŗī¸ Moderated by Michael Timothy, Business Development, NalaGeneticsâŖ
âŖ
📅 𝐅đĢđĸ𝐝𝐚𝐲, 𝟐𝟓 𝐒𝐞𝐩𝐭𝐞đĻ𝐛𝐞đĢ đŸđŸŽđŸđŸ”âŖ
🕖 19.00–20.30 WIB / 20.00–21.30 SGTâŖ
đŸ’ģ Zoom MeetingâŖ
đŸŽŸī¸ Free registration: bit.ly/GET2026âŖ
âŖ
Open to clinicians, genetic counsellors, and anyone working with hereditary cancer risk. We'd be glad to see you there.

03/09/2026

GenePath founder Dr. Mustak Ibn Ayub is offering a Course on Molecular Oncology at LifeCourse.
See the post on LifeCourse for registration.

Photos from GenePath's post 22/08/2026

𝐆𝐞𝐧𝐞𝐏𝐚𝐭𝐡 đĸđŦ 𝐩đĨ𝐞𝐚đŦ𝐞𝐝 𝐭𝐨 𝐨𝐟𝐟đĸ𝐜đĸ𝐚đĨđĨ𝐲 𝐰𝐞đĨ𝐜𝐨đĻ𝐞 𝐨𝐮đĢ 𝐧𝐞𝐰 𝐜𝐨𝐡𝐨đĢ𝐭 𝐨𝐟 đĢ𝐞đŦ𝐞𝐚đĢ𝐜𝐡 đĸ𝐧𝐭𝐞đĢ𝐧đŦ.

​As we advance our work in genomic research and longitudinal health studies, we recognize that fresh perspectives are essential to our success. At GenePath, we are committed to fostering the next generation of scientists, whose work is vital to understanding the complex intersections of genetics and human health across the lifecourse.

​𝐓𝐨 𝐨𝐮đĢ đĸ𝐧𝐭𝐞đĢ𝐧đŦ: your contributions are integral to our mission of delivering practical, evidence-based insights for global health. We look forward to your professional growth and the innovative energy you will bring to our laboratory and analytical teams.
​
𝐖𝐞 𝐰đĸđŦ𝐡 𝐲𝐨𝐮 𝐚 𝐩đĢ𝐨𝐝𝐮𝐜𝐭đĸđ¯đž 𝐚𝐧𝐝 đĸđĻ𝐩𝐚𝐜𝐭𝐟𝐮đĨ 𝐭𝐞𝐧𝐮đĢ𝐞 𝐰đĸ𝐭𝐡 𝐮đŦ.

​

19/08/2026

"āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏāĻŋāϞāĻŋāĻ‚ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āϝāĻž āϜāĻžāύāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύ"

ā§§. āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āϕ⧀?

āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ (Genetic Counseling) āĻšāϞ⧋ āĻāĻŽāύ āĻāĻ•āϟāĻŋ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝāϏ⧇āĻŦāĻž āĻĒā§āϰāĻ•ā§āϰāĻŋ⧟āĻž, āϝ⧇āĻ–āĻžāύ⧇ āĻāĻ•āϜāύ āĻĒā§āϰāĻļāĻŋāĻ•ā§āώāĻŋāϤ Genetic Counselor, Clinical Geneticist āĻ…āĻĨāĻŦāĻž āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ• āϰ⧋āĻ—ā§€ āĻ“ āϤāĻžāϰ āĻĒāϰāĻŋāĻŦāĻžāϰ⧇āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž-āχāϤāĻŋāĻšāĻžāϏ, āĻĒāĻžāϰāĻŋāĻŦāĻžāϰāĻŋāĻ• āϰ⧋āϗ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āĻāĻŦāĻ‚ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āĻŦāĻŋāĻļā§āϞ⧇āώāĻŖ āĻ•āϰ⧇ āϕ⧋āύ⧋ āϰ⧋āϗ⧇āϰ āĻŦāĻ‚āĻļāĻ—āϤ āĻā§āρāĻ•āĻŋ, āϰ⧋āϗ⧇āϰ āϏāĻŽā§āĻ­āĻžāĻŦāύāĻž, āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§ŸāϤāĻž āĻ“ āĻĢāϞāĻžāĻĢāϞ⧇āϰ āĻ…āĻ°ā§āĻĨ āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āĻŦ⧈āĻœā§āĻžāĻžāύāĻŋāĻ• āĻ“ āĻŦā§āϝāĻ•ā§āϤāĻŋāϕ⧇āĻ¨ā§āĻĻā§āϰāĻŋāĻ• āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻĒā§āϰāĻĻāĻžāύ āĻ•āϰ⧇āύāĨ¤

āĻāϰ āωāĻĻā§āĻĻ⧇āĻļā§āϝ āĻļ⧁āϧ⧁ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻžāύ⧋ āύ⧟; āĻŦāϰāĻ‚ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āφāϗ⧇ āĻ“ āĻĒāϰ⧇ āϰ⧋āĻ—ā§€āϕ⧇ āϏāĻ āĻŋāĻ• āϤāĻĨā§āϝ āĻĒā§āϰāĻĻāĻžāύ, āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻā§āρāĻ•āĻŋ āĻŦā§‹āĻāĻžāύ⧋ āĻāĻŦāĻ‚ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻ“ āĻ­āĻŦāĻŋāĻˇā§āĻ¯ā§Ž āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ-āĻĒāϰāĻŋāĻ•āĻ˛ā§āĻĒāύāĻžā§Ÿ āϏāĻšāĻžā§ŸāϤāĻž āĻ•āϰāĻžāĨ¤

⧍. āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āĻŦāϞāϤ⧇ āϕ⧀ āĻŦā§‹āĻāĻžā§Ÿ?

āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ (Cancer Genetic Counseling) āĻšāϞ⧋ āĻāĻŽāύ āĻāĻ•āϟāĻŋ āĻŦāĻŋāĻļ⧇āώāĻžā§ŸāĻŋāϤ āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āĻĒā§āϰāĻ•ā§āϰāĻŋ⧟āĻž, āϝāĻžāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āϕ⧋āύ⧋ āĻŦā§āϝāĻ•ā§āϤāĻŋāϰ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ āĻšāĻ“ā§ŸāĻžāϰ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āĻŦāĻ‚āĻļāĻ—āϤ āĻŦāĻž hereditary risk āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāĻž āĻšā§ŸāĨ¤

āĻ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻžāϧāĻžāϰāĻŖāϤ āĻŦā§āϝāĻ•ā§āϤāĻŋāϰ:
āĻŦā§āϝāĻ•ā§āϤāĻŋāĻ—āϤ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ
āĻĒāϰāĻŋāĻŦāĻžāϰ⧇āϰ āϏāĻĻāĻ¸ā§āϝāĻĻ⧇āϰ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ
āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ⧇āϰ āϧāϰāύ āĻ“ āφāĻ•ā§āϰāĻžāĻ¨ā§āϤ āĻšāĻ“ā§ŸāĻžāϰ āĻŦ⧟āϏ
āĻāĻ•āĻžāϧāĻŋāĻ• āĻĒā§āϰāϜāĻ¨ā§āĻŽā§‡ āĻāĻ•āχ āĻŦāĻž āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ⧇āϰ āωāĻĒāĻ¸ā§āĻĨāĻŋāϤāĻŋ
āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻĒā§‚āĻ°ā§āĻŦāĻŦāĻ°ā§āϤ⧀ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāĻž āĻšā§ŸāĨ¤

āĻĒā§āĻ°ā§Ÿā§‹āϜāύ⧇ BRCA1/BRCA2, TP53, APC, MLH1, MSH2, MSH6, PMS2 āχāĻ¤ā§āϝāĻžāĻĻāĻŋ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ-āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āϜāĻŋāύ⧇āϰ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻŦāĻž multigene panel testing āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϤāĻŦ⧇ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻŋāώ⧟ āĻšāĻ˛ā§‹â€”āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻžā§Ÿ āϕ⧋āύ⧋ pathogenic variant āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϞ⧇āχ āϝ⧇ āĻŦā§āϝāĻ•ā§āϤāĻŋāϰ āĻ…āĻŦāĻļā§āϝāχ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ āĻšāĻŦ⧇, āϤāĻž āύ⧟āĨ¤ āĻāĻ•āχāĻ­āĻžāĻŦ⧇, āϕ⧋āύ⧋ variant āύāĻž āĻĒāĻžāĻ“ā§ŸāĻž āϗ⧇āϞ⧇āĻ“ āϏāĻŦ āϧāϰāύ⧇āϰ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ⧇āϰ āĻā§āρāĻ•āĻŋ āϏāĻŽā§āĻĒā§‚āĻ°ā§āĻŖāĻ­āĻžāĻŦ⧇ āĻŦāĻžāĻĻ āϝāĻžā§Ÿ āύāĻžāĨ¤ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āϰ⧋āĻ—ā§€āϰ āĻŦā§āϝāĻ•ā§āϤāĻŋāĻ—āϤ āĻ“ āĻĒāĻžāϰāĻŋāĻŦāĻžāϰāĻŋāĻ• āχāϤāĻŋāĻšāĻžāϏ⧇āϰ āϏāĻ™ā§āϗ⧇ āĻŽāĻŋāϞāĻŋā§Ÿā§‡ Clinical Interpretation āĻ•āϰāϤ⧇ āĻšā§ŸāĨ¤

ā§Š. āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϜāϟāĻŋāϞ āϰ⧋āϗ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āĻ“ āĻŸā§‡āĻ¸ā§āϟ āϕ⧇āύ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ?

āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āĻ“ āωāĻĒāϝ⧁āĻ•ā§āϤ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•ā§Ÿā§‡āĻ•āϟāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻ•āĻžāϰāϪ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžā§Ÿ āĻŽā§‚āĻ˛ā§āϝāĻŦāĻžāύāĨ¤

āĻ•. āϰ⧋āϗ⧇āϰ āĻŦāĻ‚āĻļāĻ—āϤ āĻā§āρāĻ•āĻŋ āĻļāύāĻžāĻ•ā§āϤāĻ•āϰāĻŖ
āĻ•āĻŋāϛ⧁ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ āĻ“ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϜāϟāĻŋāϞ āϰ⧋āϗ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āϰ⧋āϗ⧇āϰ āĻā§āρāĻ•āĻŋ āωāĻ˛ā§āϞ⧇āĻ–āϝ⧋āĻ—ā§āϝāĻ­āĻžāĻŦ⧇ āĻŦ⧃āĻĻā§āϧāĻŋ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ā§Ÿā§‡āϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻ āϧāϰāύ⧇āϰ āĻā§āρāĻ•āĻŋ āĻļāύāĻžāĻ•ā§āϤ āĻ•āϰāĻžāϰ āϏ⧁āϝ⧋āĻ— āϤ⧈āϰāĻŋ āĻšā§ŸāĨ¤

āĻ–. āϰ⧋āĻ—ā§€āϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĒāϰāĻŋāĻ•āĻ˛ā§āĻĒāύāĻžā§Ÿ āϏāĻšāĻžā§ŸāϤāĻž
āĻ•āĻŋāϛ⧁ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻœā§‡āύ⧇āϟāĻŋāĻ• āϤāĻĨā§āϝ āϰ⧋āϗ⧇āϰ diagnosis, prognosis, treatment selection āĻŦāĻž targeted therapy āϏāĻŽā§āĻĒāĻ°ā§āϕ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻ•āĻĻ⧇āϰ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āĻ—ā§āϰāĻšāϪ⧇ āϏāĻšāĻžā§ŸāϤāĻž āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻ—. āĻŦā§āϝāĻ•ā§āϤāĻŋāϕ⧇āĻ¨ā§āĻĻā§āϰāĻŋāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž
Genomic information āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āϰ⧋āĻ—ā§€āϰ āϜāĻ¨ā§āϝ āωāĻĒāϝ⧁āĻ•ā§āϤ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻŦāĻž monitoring strategy āύāĻŋāĻ°ā§āϧāĻžāϰāϪ⧇ āϏāĻšāĻžā§ŸāĻ• āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āĻ•āĻŋāϛ⧁ āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ⧇ molecular profiling āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ⧇ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻ­ā§‚āĻŽāĻŋāĻ•āĻž āĻĒāĻžāϞāύ āĻ•āϰ⧇āĨ¤

āϘ. āĻĒāϰāĻŋāĻŦāĻžāϰ⧇āϰ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϏāĻĻāĻ¸ā§āϝāĻĻ⧇āϰ āĻā§āρāĻ•āĻŋ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ
āϝāĻĻāĻŋ āϕ⧋āύ⧋ āϰ⧋āĻ—ā§€āϰ āĻŽāĻ§ā§āϝ⧇ clinically significant hereditary variant āĻļāύāĻžāĻ•ā§āϤ āĻšā§Ÿ, āϤāĻžāĻšāϞ⧇ āĻĒāϰāĻŋāĻŦāĻžāϰ⧇āϰ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āϏāĻĻāĻ¸ā§āϝāĻĻ⧇āϰāĻ“ āύāĻŋāĻ°ā§āĻĻāĻŋāĻˇā§āϟ āĻĒāϰāĻŋāĻ¸ā§āĻĨāĻŋāϤāĻŋāϤ⧇ genetic counseling āĻ“ testing-āĻāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻ™. āφāĻ—āĻžāĻŽ āĻā§āρāĻ•āĻŋ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāĻĒāύāĻž
āωāĻšā§āϚ āĻā§āρāĻ•āĻŋāϰ āĻŦā§āϝāĻ•ā§āϤāĻŋāĻĻ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ surveillance, screening āĻŦāĻž preventive management āĻ—ā§āϰāĻšāϪ⧇āϰ āϏ⧁āϝ⧋āĻ— āϤ⧈āϰāĻŋ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āϚ. āĻ…āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§Ÿ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ“ āϭ⧁āϞ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āĻ•āĻŽāĻžāϤ⧇ āϏāĻšāĻžā§ŸāϤāĻž
Genetic counseling āϰ⧋āĻ—ā§€āϕ⧇ āĻŦā§‹āĻāĻžāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āĻ°ā§‡â€”āϕ⧋āύ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύ, āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āϏ⧀āĻŽāĻžāĻŦāĻĻā§āϧāϤāĻž āϕ⧀ āĻāĻŦāĻ‚ āĻāĻ•āϟāĻŋ genetic test-āĻāϰ āĻĢāϞāĻžāĻĢāϞ āϕ⧀āĻ­āĻžāĻŦ⧇ āĻŦā§āϝāĻžāĻ–ā§āϝāĻž āĻ•āϰāϤ⧇ āĻšāĻŦ⧇āĨ¤ āĻĢāϞ⧇ āĻļ⧁āϧ⧁āĻŽāĻžāĻ¤ā§āϰ āĻāĻ•āϟāĻŋ āϰāĻŋāĻĒā§‹āĻ°ā§āĻŸā§‡āϰ āĻ“āĻĒāϰ āĻ­āĻŋāĻ¤ā§āϤāĻŋ āĻ•āϰ⧇ āϭ⧁āϞ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āύ⧇āĻ“ā§ŸāĻžāϰ āĻā§āρāĻ•āĻŋ āĻ•āĻŽā§‡āĨ¤

ā§Ē. āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āĻ•āĻŋ āϏāϰāĻžāϏāϰāĻŋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻĒā§āϰāĻ•ā§āϰāĻŋ⧟āĻž?

āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āύāĻŋāĻœā§‡ āϏāĻžāϧāĻžāϰāĻŖāϤ āϰ⧋āϗ⧇āϰ āϏāϰāĻžāϏāϰāĻŋ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύ⧟āĨ¤ āĻāϟāĻŋ āĻāĻ•āϟāĻŋ clinical decision-support āĻāĻŦāĻ‚ risk-assessment service, āϝāĻž āϰ⧋āĻ— āύāĻŋāĻ°ā§āϪ⧟, āĻā§āρāĻ•āĻŋ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ, āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āύāĻŋāĻ°ā§āĻŦāĻžāϚāύ āĻāĻŦāĻ‚ āĻ­āĻŦāĻŋāĻˇā§āĻ¯ā§Ž āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāĻĒāύāĻžāϰ āϏāĻ™ā§āϗ⧇ āϏāĻŽāĻ¨ā§āĻŦāĻŋāϤāĻ­āĻžāĻŦ⧇ āĻĒāϰāĻŋāϚāĻžāϞāĻŋāϤ āĻšā§ŸāĨ¤

āĻ…āĻ°ā§āĻĨāĻžā§Ž, āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚āϕ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āĻŦāĻŋāĻ•āĻ˛ā§āĻĒ āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĻ⧇āĻ–āĻž āωāϚāĻŋāϤ āύ⧟āĨ¤ āĻŦāϰāĻ‚ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ āĻāϟāĻŋ āϰ⧋āĻ—ā§€āϰ āĻŽā§‚āϞ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāϰ āĻ…āĻ‚āĻļ āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦāĻž āĻĒāĻžāĻļāĻžāĻĒāĻžāĻļāĻŋ āϧāĻžāϰāĻžāĻŦāĻžāĻšāĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻĒāϰāĻŋāϚāĻžāϞāύāĻž āĻ•āϰāĻž āĻ…āϧāĻŋāĻ• āĻ•āĻžāĻ°ā§āϝāĻ•āϰāĨ¤

āωāĻĻāĻžāĻšāϰāĻŖāĻ¸ā§āĻŦāϰ⧂āĻĒ, āĻ•ā§āϝāĻžāĻ¨ā§āϏāĻžāϰ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻāĻ•āϜāύ āϰ⧋āĻ—ā§€ āĻĒā§āϰāĻĨāĻŽā§‡ āϚāĻŋāĻ•āĻŋā§ŽāϏāϕ⧇āϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ clinical evaluation-āĻāϰ āĻĒāϰ genetic counseling āĻĒ⧇āϤ⧇ āĻĒāĻžāϰ⧇āύāĨ¤ āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ā§Ÿā§‡āϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻĒā§āĻ°ā§Ÿā§‹āϜāĻ¨ā§€ā§ŸāϤāĻž āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āĻšāϞ⧇ āϤāĻžāϰ āĻĢāϞāĻžāĻĢāϞ āĻĒ⧁āύāϰāĻžā§Ÿ clinical context-āĻ āĻŦā§āϝāĻžāĻ–ā§āϝāĻž āĻ•āϰāĻž āĻšā§Ÿ āĻāĻŦāĻ‚ āĻĒā§āĻ°ā§Ÿā§‹āϜāύ āĻ…āύ⧁āϝāĻžā§Ÿā§€ oncologist, clinical geneticist, surgeon āĻŦāĻž āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻžā§‡āϰ āϏāĻ™ā§āϗ⧇ āϏāĻŽāĻ¨ā§āĻŦ⧟ āĻ•āϰ⧇ āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āĻŦā§āϝāĻŦāĻ¸ā§āĻĨāĻžāĻĒāύāĻž āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰāĻž āĻšā§ŸāĨ¤

16/08/2026

āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ DNA Fragmentation āĻ“ āĻŦāĻžāϰāĻŦāĻžāϰ āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤ: āĻĒ⧁āϰ⧁āώ⧇āϰ āĻĒā§āϰāϜāύāύāĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ⧇āϰ āϗ⧁āϰ⧁āĻ¤ā§āĻŦ

⧍ā§Ļ⧍ā§Ē āϏāĻžāϞ⧇āϰ āĻ—ā§āϰ⧀āĻˇā§āĻŽā§‡ āĻĢāĻžāĻ°ā§āϟāĻŋāϞāĻŋāϟāĻŋ āĻŦāĻŋāĻļ⧇āώāĻœā§āĻž āĻĄ. āĻ•ā§āϝāĻžāϰāĻŋ āĻŦ⧇āĻĄāĻŋāϝāĻŧ⧇āĻ¨ā§āϟ āϤāĻžāρāϰ āĻ•ā§āϞāĻŋāύāĻŋāϕ⧇ āĻāĻ• āϤāϰ⧁āĻŖ āĻĻāĻŽā§āĻĒāϤāĻŋāϰ āϏāĻ™ā§āϗ⧇ āĻŦāϏ⧇āĻ›āĻŋāϞ⧇āύāĨ¤ āĻĻ⧁āϜāύ⧇āϰ āĻŦ⧟āϏāχ āĻ›āĻŋāϞ ā§Šā§¨ āĻŦāĻ›āϰāĨ¤ āĻĒā§āϰāĻžā§Ÿ āĻĒāĻžāρāϚ āĻŦāĻ›āϰ āϧāϰ⧇ āϤāĻžāρāϰāĻž āϏāĻ¨ā§āϤāĻžāύ āύ⧇āĻ“ā§ŸāĻžāϰ āĻšā§‡āĻˇā§āϟāĻž āĻ•āϰāĻ›āĻŋāϞ⧇āύāĨ¤ āĻāϰ āĻŽāĻ§ā§āϝ⧇ āĻāĻ•āĻžāϧāĻŋāĻ•āĻŦāĻžāϰ IVF āĻ•āϰāĻŋā§Ÿā§‡āϛ⧇āύ, āĻ•āĻŋāĻ¨ā§āϤ⧁ āϕ⧋āύ⧋āĻŦāĻžāϰāχ āĻ•āĻžāĻ™ā§āĻ•ā§āώāĻŋāϤ āĻĢāϞ āĻĒāĻžāύāύāĻŋāĨ¤ āĻ•āĻ–āύ⧋ āĻ­ā§āϰ⧂āĻŖ āϜāϰāĻžā§Ÿā§āϤ⧇ āĻ āĻŋāĻ•āĻ­āĻžāĻŦ⧇ āĻ¸ā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ŸāύāĻŋ, āĻ•āĻ–āύ⧋ āĻ—āĻ°ā§āĻ­āϧāĻžāϰāϪ⧇āϰ āĻĒāϰ āϖ⧁āĻŦ āĻĻā§āϰ⧁āϤāχ āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤ āĻšā§Ÿā§‡āϛ⧇āĨ¤ āĻŦāĻžāϰāĻŦāĻžāϰ āĻŦā§āϝāĻ°ā§āĻĨāϤāĻžāϰ āĻĒāϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ•āĻ­āĻžāĻŦ⧇āχ āϤāĻžāρāĻĻ⧇āϰ āĻŽāĻ§ā§āϝ⧇ āĻšāϤāĻžāĻļāĻž āĻ“ āĻ…āύāĻŋāĻļā§āϚ⧟āϤāĻž āϤ⧈āϰāĻŋ āĻšā§Ÿā§‡āĻ›āĻŋāϞāĨ¤

āĻ āϏāĻŽā§Ÿ āĻĒāĻ°ā§āϝāĻ¨ā§āϤ āĻĻāĻŽā§āĻĒāϤāĻŋāϰ āĻĒā§āϰāĻžā§Ÿ āϏāĻŦ āĻĒā§āϰāϚāϞāĻŋāϤ āĻĒāϰ⧀āĻ•ā§āώāĻžāχ āĻ•āϰāĻž āĻšā§Ÿā§‡ āĻ—āĻŋā§Ÿā§‡āĻ›āĻŋāϞāĨ¤ āϰāĻ•ā§āϤ āĻĒāϰ⧀āĻ•ā§āώāĻž, āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ āϏāĻ‚āĻ–ā§āϝāĻž āĻ“ āĻ—āϤāĻŋāĻļā§€āϞāϤāĻž āĻĒāϰ⧀āĻ•ā§āώāĻž, āĻāĻŽāύāĻ•āĻŋ āύāĻžāϰ⧀āϰ āϜāϰāĻžā§Ÿā§āϰ āĻ—āĻ āύāĻ“ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āĻšā§Ÿā§‡āĻ›āĻŋāϞāĨ¤ āĻ•āĻŋāĻ¨ā§āϤ⧁ āϕ⧋āύ⧋ āĻĒāϰ⧀āĻ•ā§āώāĻžāχ āϏāĻŽāĻ¸ā§āϝāĻžāϟāĻŋāϰ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āĻŦā§āϝāĻžāĻ–ā§āϝāĻž āĻĻāĻŋāϤ⧇ āĻĒāĻžāϰāĻ›āĻŋāϞ āύāĻžāĨ¤

āϤāĻ–āύ āĻŦ⧇āĻĄāĻŋāϝāĻŧ⧇āĻ¨ā§āϟ āĻāĻ•āϟ⧁ āĻ­āĻŋāĻ¨ā§āύāĻ­āĻžāĻŦ⧇ āĻ­āĻžāĻŦāϞ⧇āύāĨ¤ āϤāĻŋāύāĻŋ āĻĒ⧁āϰ⧁āώ āϏāĻ™ā§āĻ—ā§€āϰ āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ DNA fragmentation āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻžāϰ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ āύāĻŋāϞ⧇āύāĨ¤ āĻĒāϰ⧀āĻ•ā§āώāĻžā§Ÿ āĻĻ⧇āĻ–āĻž āϗ⧇āϞ, āϤāĻžāρāϰ āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϤ⧇ āĻŽāĻžāĻāĻžāϰāĻŋ āĻŽāĻžāĻ¤ā§āϰāĻžāϰ DNA āĻ•ā§āώāϤāĻŋ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤

āĻāϰāĻĒāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāϰ āĻ…āĻ‚āĻļ āĻšāĻŋāϏ⧇āĻŦ⧇ āϤāĻžāρāϕ⧇ āĻœā§€āĻŦāύāϝāĻžāĻ¤ā§āϰāĻžā§Ÿ āĻ•āĻŋāϛ⧁ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύ āφāύāĻžāϰ āĻĒāϰāĻžāĻŽāĻ°ā§āĻļ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§ŸāĨ¤ āϤāĻŋāύāĻŋ āϧ⧂āĻŽāĻĒāĻžāύ āĻ“ āĻŽāĻĻā§āϝāĻĒāĻžāύ āĻŦāĻ¨ā§āϧ āĻ•āϰ⧇āύ, āύāĻŋ⧟āĻŽāĻŋāϤ āĻŦā§āϝāĻžā§ŸāĻžāĻŽ āĻļ⧁āϰ⧁ āĻ•āϰ⧇āύ āĻāĻŦāĻ‚ āĻ­āĻŋāϟāĻžāĻŽāĻŋāύ āϏāĻžāĻĒā§āϞāĻŋāĻŽā§‡āĻ¨ā§āϟ āĻ—ā§āϰāĻšāĻŖ āĻ•āϰ⧇āύāĨ¤ āĻĒā§āϰāĻžā§Ÿ āĻ›ā§Ÿ āĻŽāĻžāϏ āĻĒāϰ āĻĻāĻŽā§āĻĒāϤāĻŋ āφāĻŦāĻžāϰ IVF-āĻāϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻ­ā§āϰ⧂āĻŖ āϤ⧈āϰāĻŋ āĻ•āϰ⧇āύāĨ¤ āĻāĻŦāĻžāϰ āĻ—āĻ˛ā§āĻĒāϟāĻž āĻ…āĻ¨ā§āϝāϰāĻ•āĻŽ āĻ›āĻŋāϞāĨ¤ āĻļ⧇āώ āĻĒāĻ°ā§āϝāĻ¨ā§āϤ āϤāĻžāρāĻĻ⧇āϰ āĻāĻ•āϟāĻŋ āϏ⧁āĻ¸ā§āĻĨ āĻĒ⧁āĻ¤ā§āϰāϏāĻ¨ā§āϤāĻžāύ āϜāĻ¨ā§āĻŽ āĻ¨ā§‡ā§ŸāĨ¤

āĻāχ āϘāϟāύāĻž āĻāĻ•āϟāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻŋāώ⧟ āϏāĻžāĻŽāύ⧇ āύāĻŋā§Ÿā§‡ āφāĻ¸ā§‡â€”āϏāĻ¨ā§āϤāĻžāύ āϧāĻžāϰāϪ⧇āϰ āϏāĻŽāĻ¸ā§āϝāĻžāϕ⧇ āĻļ⧁āϧ⧁ āύāĻžāϰ⧀āϰ āĻĻāĻŋāĻ• āĻĨ⧇āϕ⧇ āĻĻ⧇āĻ–āϞ⧇ āĻĒ⧁āϰ⧋ āϚāĻŋāĻ¤ā§āϰāϟāĻŋ āĻĒāĻžāĻ“ā§ŸāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

āϏāĻžāϧāĻžāϰāĻŖāϤ āĻĒ⧁āϰ⧁āώ⧇āϰ āĻŦāĻ¨ā§āĻ§ā§āϝāĻžāĻ¤ā§āĻŦ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ⧇āϰ āϏāĻŽā§Ÿ āĻŦā§€āĻ°ā§āϝ⧇āϰ āĻĒāϰāĻŋāĻŽāĻžāĻŖ, āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ āϏāĻ‚āĻ–ā§āϝāĻž, āĻ—āĻ āύ āĻāĻŦāĻ‚ āĻ—āϤāĻŋāĻļā§€āϞāϤāĻž āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰāĻž āĻšā§ŸāĨ¤ āĻ•āĻŋāĻ¨ā§āϤ⧁ āĻāϏāĻŦ āĻĒāϰ⧀āĻ•ā§āώāĻžā§Ÿ āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ āϭ⧇āϤāϰ⧇āϰ DNA āĻ•āϤāϟāĻž āĻ…āĻ•ā§āώāϤ āφāϛ⧇, āϏ⧇āϟāĻŋ āϏāĻŦāϏāĻŽā§Ÿ āĻŦā§‹āĻāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤ āĻ…āĻĨāϚ āϏāĻžāĻŽā§āĻĒā§āϰāϤāĻŋāĻ• āĻ—āĻŦ⧇āώāĻŖāĻžāϗ⧁āϞ⧋ āχāĻ™ā§āĻ—āĻŋāϤ āĻĻāĻŋāĻšā§āϛ⧇ āϝ⧇ āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ DNA-āϤ⧇ āĻ…āϤāĻŋāϰāĻŋāĻ•ā§āϤ āĻ•ā§āώāϤāĻŋ āĻĨāĻžāĻ•āϞ⧇ āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤ⧇āϰ āĻā§āρāĻ•āĻŋ āĻŦāĻžā§œāϤ⧇ āĻĒāĻžāϰ⧇, IVF-āĻāϰ āϏāĻĢāϞāϤāĻž āĻ•āĻŽāϤ⧇ āĻĒāĻžāϰ⧇ āĻāĻŦāĻ‚ āĻ­ā§āϰ⧂āϪ⧇āϰ āĻĒā§āϰāĻžāĻĨāĻŽāĻŋāĻ• āĻŦāĻŋāĻ•āĻžāĻļ āĻŦā§āϝāĻžāĻšāϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ DNA āϕ⧇āύ āĻ•ā§āώāϤāĻŋāĻ—ā§āϰāĻ¸ā§āϤ āĻšā§Ÿ, āϤāĻžāϰāĻ“ āĻāĻ•āĻ• āϕ⧋āύ⧋ āωāĻ¤ā§āϤāϰ āύ⧇āχāĨ¤ āĻŦ⧟āϏ, āϧ⧂āĻŽāĻĒāĻžāύ, āĻŽāĻĻā§āϝāĻĒāĻžāύ, āĻ•āĻŋāϛ⧁ āĻŽāĻžāĻĻāĻ•, āĻĒāϰāĻŋāĻŦ⧇āĻļāĻ—āϤ āĻŦāĻŋāώāĻžāĻ•ā§āϤ āĻĒāĻĻāĻžāĻ°ā§āĻĨ āĻāĻŦāĻ‚ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āĻœā§€āĻŦāύāϝāĻžāĻĒāύ-āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻ•āĻžāϰāĻŖ āĻāϰ āϏāĻ™ā§āϗ⧇ āϝ⧁āĻ•ā§āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āϤāĻŦ⧇ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻŋāώ⧟ āĻšāĻ˛ā§‹â€”āϏāĻŦ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ DNA āĻ•ā§āώāϤāĻŋāϰ āĻ•āĻžāϰāĻŖ āĻŦāĻž āĻāϰ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āϕ⧀ āĻšāĻ“ā§ŸāĻž āωāϚāĻŋāϤ, āϤāĻž āĻāĻ–āύ⧋ āĻĒ⧁āϰ⧋āĻĒ⧁āϰāĻŋ āĻĒāϰāĻŋāĻˇā§āĻ•āĻžāϰ āύ⧟āĨ¤

āĻāχ āĻ•āĻžāϰāϪ⧇āχ s***m DNA fragmentation test āĻāĻ–āύ⧋ āϏāĻŦāĻžāϰ āϜāĻ¨ā§āϝ āύāĻŋ⧟āĻŽāĻŋāϤ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦāĻŋāĻŦ⧇āϚāĻŋāϤ āĻšā§Ÿ āύāĻžāĨ¤ āϤāĻŦ⧇ āϚāĻŋāĻ•āĻŋā§ŽāϏāĻžāĻŦāĻŋāĻœā§āĻžāĻžāύ āϧ⧀āϰ⧇ āϧ⧀āϰ⧇ āĻāϰ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāϕ⧇ āĻ¸ā§āĻŦā§€āĻ•āĻžāϰ āĻ•āϰāϛ⧇āĨ¤ American Society for Reproductive Medicine (ASRM)-āĻāϰ āĻšāĻžāϞāύāĻžāĻ—āĻžāĻĻ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻžā§Ÿ āĻŦāĻžāϰāĻŦāĻžāϰ āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻāχ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āϝ⧇āϤ⧇ āĻĒāĻžāϰ⧇ āĻŦāϞ⧇ āωāĻ˛ā§āϞ⧇āĻ– āĻ•āϰāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤ āĻāĻ•āχ āϏāĻ™ā§āϗ⧇ āϤāĻžāϰāĻž āϏāϤāĻ°ā§āĻ• āĻ•āϰ⧇āϛ⧇ āϝ⧇ DNA fragmentation āĻ•āĻŽāĻžāύ⧋āϰ āĻŽāĻžāĻ§ā§āϝāĻŽā§‡ āĻ—āĻ°ā§āĻ­āϧāĻžāϰāϪ⧇āϰ āĻĢāϞāĻžāĻĢāϞ āύāĻŋāĻļā§āϚāĻŋāϤāĻ­āĻžāĻŦ⧇ āωāĻ¨ā§āύāϤ āĻšā§Ÿ āĻ•āĻŋ āύāĻž, āϤāĻž āϜāĻžāύāϤ⧇ āφāϰāĻ“ āĻ—āĻŦ⧇āώāĻŖāĻž āĻĒā§āĻ°ā§Ÿā§‹āϜāύāĨ¤

āĻāĻ–āĻžāύ⧇ āϏāĻŦāĻšā§‡ā§Ÿā§‡ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻĒāϰāĻŋāĻŦāĻ°ā§āϤāύāϟāĻŋ āϏāĻŽā§āĻ­āĻŦāϤ āĻĻ⧃āĻˇā§āϟāĻŋāĻ­āĻ™ā§āĻ—āĻŋāϰāĨ¤ āĻŦāĻšā§ āĻŦāĻ›āϰ āϧāϰ⧇ āĻŦāĻ¨ā§āĻ§ā§āϝāĻžāĻ¤ā§āĻŦ āĻ“ āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤ⧇āϰ āφāϞ⧋āϚāύāĻžā§Ÿ āύāĻžāϰ⧀āϰ āĻļāϰ⧀āϰ āĻ“ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ⧇āϰ āĻ“āĻĒāϰ āĻŦ⧇āĻļāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦ āĻĻ⧇āĻ“ā§ŸāĻž āĻšā§Ÿā§‡āϛ⧇āĨ¤ āĻ•āĻŋāĻ¨ā§āϤ⧁ āĻŦāĻžāĻ¸ā§āϤāĻŦ⧇ āϏāĻ¨ā§āϤāĻžāύ āϧāĻžāϰāĻŖ āĻāĻ•āϟāĻŋ āĻĻ⧁āχ āĻĒāĻ•ā§āώ⧇āϰ āĻĒā§āϰāϜāύāύ āĻĒā§āϰāĻ•ā§āϰāĻŋ⧟āĻžāĨ¤ American Urological Association-āĻāϰ āϤāĻĨā§āϝ āĻ…āύ⧁āϝāĻžā§Ÿā§€, āĻĒā§āϰāĻžā§Ÿ ⧍ā§Ļ āĻļāϤāĻžāĻ‚āĻļ āĻŦāĻ¨ā§āĻ§ā§āϝāĻžāĻ¤ā§āĻŦ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āĻļ⧁āϧ⧁āĻŽāĻžāĻ¤ā§āϰ āĻĒ⧁āϰ⧁āώ⧇āϰ āĻ•āĻžāϰāĻŖ āĻĻāĻžā§Ÿā§€, āφāϰ āφāϰāĻ“ ā§Šā§Ļ–ā§Ēā§Ļ āĻļāϤāĻžāĻ‚āĻļ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āύāĻžāϰ⧀ āĻ“ āĻĒ⧁āϰ⧁āώ āωāĻ­ā§Ÿā§‡āϰ āĻ•āĻžāϰāĻŖ āĻ­ā§‚āĻŽāĻŋāĻ•āĻž āϰāĻžāϖ⧇āĨ¤

āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ DNA-āϕ⧇ āĻ…āύ⧇āĻ•āϟāĻž āĻāĻ•āϟāĻŋ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻž āĻŦāĻ‡ā§Ÿā§‡āϰ āϏāĻ™ā§āϗ⧇ āϤ⧁āϞāύāĻž āĻ•āϰāĻž āϝāĻžā§ŸāĨ¤ āĻŦāχāϟāĻŋ āĻŦāĻžāχāϰ⧇ āĻĨ⧇āϕ⧇ āĻ āĻŋāĻ•āĻ āĻžāĻ• āĻĻ⧇āĻ–āĻžāϞ⧇āĻ“ āϭ⧇āϤāϰ⧇ āϝāĻĻāĻŋ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āϜāĻžā§ŸāĻ—āĻžā§Ÿ āĻ…āύ⧇āĻ• āϭ⧁āϞ āĻĨāĻžāϕ⧇, āϤāĻžāĻšāϞ⧇ āύāĻŋāώ⧇āĻ• āϘāϟāϞ⧇āĻ“ āĻ­ā§āϰ⧂āϪ⧇āϰ āĻ¸ā§āĻŦāĻžāĻ­āĻžāĻŦāĻŋāĻ• āĻŦāĻŋāĻ•āĻžāĻļ āĻŦāĻžāϧāĻžāĻ—ā§āϰāĻ¸ā§āϤ āĻšāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤ āĻ…āĻ°ā§āĻĨāĻžā§Ž, āĻļ⧁āϧ⧁ āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁ āĻĄāĻŋāĻŽā§āĻŦāĻžāϪ⧁āϤ⧇ āĻĒ⧌āρāĻ›āĻžāϤ⧇ āĻĒāĻžāϰāϞ⧇āχ āϏāĻŦāĻ•āĻŋāϛ⧁ āĻ āĻŋāĻ• āφāĻ›ā§‡â€”āĻāĻŽāύāϟāĻž āϧāϰ⧇ āύ⧇āĻ“ā§ŸāĻž āϝāĻžā§Ÿ āύāĻžāĨ¤

āϤāĻŦ⧇ āĻāχ āĻŦāĻŋāώ⧟āϟāĻŋāϰ āφāϰ⧇āĻ•āϟāĻŋ āĻŽāĻžāύāĻŦāĻŋāĻ• āĻĻāĻŋāĻ•āĻ“ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤ āĻŦāĻ¨ā§āĻ§ā§āϝāĻžāĻ¤ā§āĻŦāϕ⧇ āĻ…āύ⧇āĻ• āϏāĻŽāĻžāĻœā§‡ āĻāĻ–āύ⧋ āĻĒ⧁āϰ⧁āώāĻ¤ā§āĻŦ āĻŦāĻž āύāĻžāϰ⧀āĻ¤ā§āĻŦ⧇āϰ āϏāĻ™ā§āϗ⧇ āϜ⧜āĻŋā§Ÿā§‡ āĻĻ⧇āĻ–āĻž āĻšā§ŸāĨ¤ āĻŦāĻŋāĻļ⧇āώ āĻ•āϰ⧇ āĻĒ⧁āϰ⧁āώāĻĻ⧇āϰ āĻ•ā§āώ⧇āĻ¤ā§āϰ⧇ āϏāĻ¨ā§āϤāĻžāύ āϜāĻ¨ā§āĻŽāĻĻāĻžāύ⧇āϰ āϏāĻ•ā§āώāĻŽāϤāĻžāϕ⧇ āĻ…āύ⧇āĻ• āϏāĻŽā§Ÿ āĻĒ⧁āϰ⧁āώāĻ¤ā§āĻŦ⧇āϰ āĻŽāĻžāĻĒāĻ•āĻžāĻ āĻŋ āĻšāĻŋāϏ⧇āĻŦ⧇ āĻŦāĻŋāĻŦ⧇āϚāύāĻž āĻ•āϰāĻž āĻšā§ŸāĨ¤ āĻĢāϞ⧇ āϏāĻ¨ā§āϤāĻžāύ āύāĻž āĻšāϞ⧇ āĻ…āύ⧇āĻ• āĻĒ⧁āϰ⧁āώāĻ“ āϞāĻœā§āϜāĻž, āĻ…āĻĒāϰāĻžāϧāĻŦā§‹āϧ āĻŦāĻž āĻŽāĻžāύāϏāĻŋāĻ• āϚāĻžāĻĒ⧇ āĻ­ā§‹āϗ⧇āύāĨ¤

āϤāĻžāχ āĻŦāĻ¨ā§āĻ§ā§āϝāĻžāĻ¤ā§āĻŦ āĻŦāĻž āĻŦāĻžāϰāĻŦāĻžāϰ āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤāϕ⧇ āĻļ⧁āϧ⧁ āύāĻžāϰ⧀āϰ āϏāĻŽāĻ¸ā§āϝāĻž āĻšāĻŋāϏ⧇āĻŦ⧇ āĻĻ⧇āĻ–āĻžāϰ āϏāĻŽā§Ÿ āϏāĻŽā§āĻ­āĻŦāϤ āĻļ⧇āώ āĻšā§Ÿā§‡ āφāϏāϛ⧇āĨ¤ āϏāĻ¨ā§āϤāĻžāύ āϧāĻžāϰāϪ⧇āϰ āĻĒāĻĨ⧇ āύāĻžāϰ⧀ āĻ“ āĻĒ⧁āϰ⧁āĻˇâ€”āĻĻ⧁āϜāύ⧇āϰ āĻĒā§āϰāϜāύāύāĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ⧇āϰāχ āϗ⧁āϰ⧁āĻ¤ā§āĻŦ āĻ°ā§Ÿā§‡āϛ⧇āĨ¤ āĻļ⧁āĻ•ā§āϰāĻžāϪ⧁āϰ DNA āύāĻŋā§Ÿā§‡ āύāϤ⧁āύ āĻ—āĻŦ⧇āώāĻŖāĻžāϗ⧁āϞ⧋ āϏ⧇āχ āωāĻĒāϞāĻŦā§āϧāĻŋāϕ⧇āχ āφāϰāĻ“ āĻļāĻ•ā§āϤāĻŋāĻļāĻžāϞ⧀ āĻ•āϰāϛ⧇āĨ¤

āϤāĻŦ⧇ āĻāϟāĻŋāĻ“ āĻŽāύ⧇ āϰāĻžāĻ–āĻž āϜāϰ⧁āϰāĻŋ āϝ⧇ s***m DNA fragmentation āĻāĻ•āϟāĻŋ āϏāĻŽā§āĻ­āĻžāĻŦā§āϝ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ āĻŦāĻŋāώ⧟ āĻšāϞ⧇āĻ“ āĻāϟāĻŋ āĻŦāĻ¨ā§āĻ§ā§āϝāĻžāĻ¤ā§āĻŦ āĻŦāĻž āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤ⧇āϰ āĻāĻ•āĻŽāĻžāĻ¤ā§āϰ āĻ•āĻžāϰāĻŖ āύ⧟āĨ¤ āĻ āĻŦāĻŋāĻˇā§Ÿā§‡ āĻ—āĻŦ⧇āώāĻŖāĻž āĻāĻ–āύāĻ“ āϚāϞāϛ⧇ āĻāĻŦāĻ‚ āĻĒāϰ⧀āĻ•ā§āώāĻžāϰ āĻĢāϞāĻžāĻĢāϞāϕ⧇ āϏāĻŦāϏāĻŽā§Ÿ āĻĻāĻŽā§āĻĒāϤāĻŋāϰ āϏāĻžāĻŽāĻ—ā§āϰāĻŋāĻ• āϚāĻŋāĻ•āĻŋā§ŽāϏāĻž āχāϤāĻŋāĻšāĻžāϏ⧇āϰ āϏāĻ™ā§āϗ⧇ āĻŽāĻŋāϞāĻŋā§Ÿā§‡āχ āĻŽā§‚āĻ˛ā§āϝāĻžā§Ÿāύ āĻ•āϰāĻž āωāϚāĻŋāϤāĨ¤

āϤāĻĨā§āϝāϏ⧂āĻ¤ā§āϰ: Scientific American

# āĻŦāĻ¨ā§āĻ§ā§āϝāĻžāĻ¤ā§āĻŦ # DNA_Fragmentation

Photos from GenePath's post 09/08/2026

āĻ—āϤāĻ•āĻžāϞ ā§Ž āφāĻ—āĻˇā§āϟ GenePath āĻāϰ āϏāĻšāϝ⧋āĻ—ā§€āϤāĻžā§Ÿ iNQUEST āĻ“ NYBB āĻāϰ āωāĻĻā§āϝ⧋āϗ⧇ GenePath Centre āĻ Intensive Hands on Training Course on "Metaginomics Data Analyse" āĻļā§€āĻ°ā§āώāĻ• āĻļāĻŋāϰ⧋āύāĻžāĻŽā§‡ Inquest-NYBB Omics Training Series-2026 āϏāĻĢāϞāĻ­āĻžāĻŦ⧇ āĻ…āύ⧁āĻˇā§āĻ āĻŋāϤ āĻšā§Ÿā§‡āϛ⧇āĨ¤

āϏāĻžāϰāĻž āĻĻ⧇āĻļ⧇āϰ āĻŦāĻŋāĻ­āĻŋāĻ¨ā§āύ āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻžāύ⧇āϰ āĻļāĻŋāĻ•ā§āώāĻžāĻ°ā§āĻĨā§€ āĻ“ āϤāϰ⧁āĻŖ āĻ—āĻŦ⧇āώāĻ•āĻ—āĻŖ āωāĻĒāĻ¸ā§āĻĨāĻŋāϤ āĻ›āĻŋāϞ⧇āύāĨ¤ āĻĻ⧇āĻļ⧇āϰ āϤāϰ⧁āĻŖāĻĻ⧇āϰ āĻ—āĻŦ⧇āώāĻŖāĻžāϰ āĻŽā§ŒāϞāĻŋāĻ• āĻļāĻŋāĻ•ā§āώāĻžāĻĻāĻžāύ āĻ“ āĻ—āĻŦ⧇āώāĻŖāĻžāϰ āϏ⧁āϝ⧋āĻ— āϤ⧈āϰāĻŋāϤ⧇ GenePath āĻ…āĻ—ā§āϰāĻŖā§€ āϭ⧁āĻŽāĻŋāĻ•āĻž āĻĒāĻžāϞāύ āĻ•āϰ⧇ āϝāĻžāĻŦ⧇āĨ¤

Photos from GenePath's post 27/07/2026

⧍ā§Ģ āϜ⧁āϞāĻžāχ, ⧍ā§Ļ⧍ā§Ŧ āϜāĻŋāύāĻĒāĻžāĻĨ (GenePath)-āĻāϰ āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻžāϤāĻž āĻĄ. āĻŽā§āĻļāϤāĻžāĻ• āχāĻŦāύ⧇ āĻ†ā§Ÿā§‚āĻŦ āϚāĻŸā§āϟāĻ—ā§āϰāĻžāĻŽā§‡āϰ āϜāĻŋāύāĻ•ā§‹ā§Ÿā§‡āĻ¸ā§āϟ āĻāĻŦāĻ‚ āĻšā§‹ā§ŸāĻžāχāϟ āĻĢāĻžāωāĻ¨ā§āĻĄā§‡āĻļāύ-āĻāϰ āϝ⧌āĻĨ āωāĻĻā§āϝ⧋āϗ⧇ āĻ†ā§Ÿā§‹āϜāĻŋāϤ āĻ“ā§ŸāĻžāĻ°ā§āĻ•āĻļāĻĒ⧇ āĻĒā§āϰāϜāύāύ āĻ¸ā§āĻŦāĻžāĻ¸ā§āĻĨā§āϝ āĻ“ āĻ—āĻ°ā§āĻ­āϧāĻžāϰāϪ⧇āϰ āϏāĻžāĻĨ⧇ āϏāĻ‚āĻļā§āϞāĻŋāĻˇā§āϟ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻŸā§‡āĻ¸ā§āϟ āĻāĻŦāĻ‚ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āĻŦāĻŋāĻˇā§Ÿā§‡ āχāĻ¨ā§āϟāĻžāϰāĻāĻ•āϟāĻŋāĻ­ āϏ⧇āĻļāύ āĻĒāϰāĻŋāϚāĻžāϞāύāĻž āĻ•āϰ⧇āύāĨ¤

āĻŽāĻžā§Ÿā§‡āĻĻ⧇āϰ āĻ—āĻ°ā§āĻ­āϧāĻžāϰāϪ⧇āϰ āĻ…āύ⧇āĻ• āĻŦāĻŋāώ⧟ āĻœā§‡āύ⧇āϟāĻŋāĻ•āϏ (genetics) āĻĻā§āĻŦāĻžāϰāĻž āύāĻŋ⧟āĻ¨ā§āĻ¤ā§āϰāĻŋāϤāĨ¤ āĻŦāĻŋāĻļ⧇āώāϤ āϝāĻžāϰāĻž āĻŦ⧇āĻļāĻŋ āĻŦ⧟āϏ⧇ āϏāĻ¨ā§āϤāĻžāύ āĻ—ā§āϰāĻšāĻŖ āĻ•āϰ⧇āύ, āϝāĻžāĻĻ⧇āϰ āĻ—āĻ°ā§āĻ­āĻĒāĻžāϤ⧇āϰ āχāϤāĻŋāĻšāĻžāϏ āφāϛ⧇ āĻ•āĻŋāĻ‚āĻŦāĻž āϜāĻ¨ā§āĻŽā§‡āϰ āĻĒāϰāĻĒāϰāχ āĻŦāĻžāĻšā§āϚāĻž āĻŽāĻžāϰāĻž āϝāĻžā§Ÿ, āĻ•āĻŋāĻ‚āĻŦāĻž āĻŽā§ƒāϤ āĻŦāĻžāĻšā§āϚāĻž āĻĒā§āϰāϏāĻŦ āĻšā§Ÿ, āϤāĻžāĻĻ⧇āϰ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻŸā§‡āĻ¸ā§āϟ āĻ“ āĻœā§‡āύ⧇āϟāĻŋāĻ• āĻ•āĻžāωāĻ¨ā§āϏ⧇āϞāĻŋāĻ‚ āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖāĨ¤
GenePath-āĻāϰ āĻĒāĻ•ā§āώ āĻĨ⧇āϕ⧇ āĻāĻŽāύ āĻ†ā§Ÿā§‹āϜāύ āφāϰ⧋ āĻ…āĻŦā§āϝāĻšāϤ āĻĨāĻžāĻ•āĻŦ⧇āĨ¤ āĻĻ⧇āĻļ⧇āϰ āĻ…āĻ¨ā§āϝāĻžāĻ¨ā§āϝ āĻ…āĻžā§āϚāϞ⧇āĻ“ āĻ›ā§œāĻŋā§Ÿā§‡ āϝāĻžāĻ• āĻ āϏāĻ‚āĻ•ā§āϰāĻžāĻ¨ā§āϤ āϤāĻĨā§āϝ āĻ“ āϏ⧇āĻŦāĻžāĨ¤

22/07/2026

GenePath Founder, Dr. Mustak Ibn Ayub will facilitate a workshop on Genetic Testing and Genetic Counselling in Chattogram, bringing together healthcare professionals and stakeholders to enhance knowledge and practical expertise in this rapidly evolving field.

This initiative reflects Dr. Ayub's continued commitment to expanding awareness, capacity, and professional expertise in genetic testing and genetic counselling across Bangladesh. Through such educational programs, GenePath aims to strengthen the country's capabilities in precision medicine and genomic healthcare.

GenePath looks forward to organizing many more educational workshops and training events across the country in the future.

15/07/2026

Due to high demand from enthusiastic participants outside of Dhaka and abroad, we are hosting this session online.âŖâŖâŖ
âŖâŖâŖ
LifeCourse Presents 𝐆𝐞𝐧𝐞𝐏𝐚𝐭𝐡 𝐎𝐧đĨđĸ𝐧𝐞 𝐖𝐨đĢ𝐤đŦ𝐡𝐨𝐩 𝐨𝐧 𝐆𝐞𝐧𝐞𝐭đĸ𝐜 𝐓𝐞đŦ𝐭đĸ𝐧𝐠 & 𝐆𝐞𝐧𝐞𝐭đĸ𝐜 𝐂𝐨𝐮𝐧đŦ𝐞đĨđĨđĸđ§đ âŖâŖâŖâŖ
âŖâŖâŖ
📅 Date & Time: 𝟑𝟏 𝐉𝐮đĨ𝐲 & 𝟏-𝟐 𝐀𝐮𝐠 𝟐𝟎𝟐𝟔 || 𝟗:𝟑𝟎 𝐏𝐌 – 𝟏𝟏:𝟑𝟎 đđŒâŖ
âŖâŖâŖ
📍 𝐏đĨ𝐚𝐭𝐟𝐨đĢđĻ: Held online via Zoom.âŖâŖâŖ
âŖâŖâŖ
👨‍🎓𝐖𝐨đĢ𝐤đŦ𝐡𝐨𝐩 𝐅𝐚𝐜đĸđĨđĸ𝐭𝐚𝐭𝐨đĢ:âŖâŖ
Dr. Mustak Ibn AyubâŖâŖâŖâŖ
​DPhil in Oncology, University of OxfordâŖâŖâŖâŖ
​Fellowship in Cancer Genetic Services, National Cancer Centre Singapore (NCCS)âŖâŖâŖâŖ
​Associate Professor, Dept. of Genetic Engineering & Biotechnology, University of DhakaâŖâŖâŖâŖ
​Founder, GenePath & HealthSynchâŖâŖâŖâŖ
âŖâŖâŖ
đŸ—“ī¸ 𝐏đĢ𝐨𝐠đĢ𝐚đĻ 𝐇đĸ𝐠𝐡đĨđĸ𝐠𝐡𝐭đŦ:âŖâŖ
🔹 Lectures on Human Genetics, Genetic Testing & Counselling ApproachesâŖâŖâŖâŖ
🔹 Case Discussions & Interactive Q&AâŖâŖâŖâŖ
🔹 Group Work: Research Ideas in Medical GeneticsâŖâŖâŖâŖ
🔹 Networking & Knowledge SharingâŖâŖâŖâŖ
âŖ
𝐒𝐩𝐞𝐜đĸ𝐚đĨ 𝐀𝐭𝐭đĢ𝐚𝐜𝐭đĸ𝐨𝐧: đ˜Šđ˜°đ˜¯đ˜ĩđ˜Ēđ˜¯đ˜ļ𝘰đ˜ļ𝘴 𝘙đ˜Ļ𝘴đ˜Ļđ˜ĸđ˜ŗđ˜¤đ˜Š đ˜Œđ˜¯đ˜¨đ˜ĸ𝘨đ˜Ļ𝘮đ˜Ļđ˜¯đ˜ĩ đ˜ĸđ˜¯đ˜Ĩ 𝘑𝘰đ˜ļđ˜ŗđ˜¯đ˜ĸ𝘭 𝘗đ˜ļđ˜Ŗđ˜­đ˜Ē𝘤đ˜ĸđ˜ĩđ˜Ēđ˜°đ˜¯ (𝘚đ˜Ļ𝘭đ˜Ļ𝘤đ˜ĩđ˜Ļđ˜Ĩ 𝘊đ˜ĸđ˜¯đ˜Ĩđ˜Ēđ˜Ĩđ˜ĸđ˜ĩđ˜Ļ)âŖ
âŖâŖâŖ
🎁 𝐖𝐨đĢ𝐤đŦ𝐡𝐨𝐩 𝐊đĸ𝐭đŦ:âŖâŖ
✔ Comprehensive lecture handouts âŖâŖâŖâŖ
✔ Limited-time access to session recordings (30 days)âŖâŖâŖ
âŖâŖâŖ
đŸ’ĩ 𝐑𝐞𝐠đĸđŦ𝐭đĢ𝐚𝐭đĸ𝐨𝐧 𝐅𝐞𝐞đŦ: 2,000 TK for Students || 3,000 TK for ProfessionalsâŖâŖâŖâŖ
âŖâŖâŖ
👤 𝐖𝐡𝐨 𝐒𝐡𝐨𝐮đĨ𝐝 𝐉𝐨đĸ𝐧?âŖâŖ
🔹 Professionals & ResearchersâŖâŖâŖâŖ
🔹 Students of Biological SciencesâŖâŖâŖâŖ
🔹 Medical Students & CliniciansâŖâŖâŖâŖ
âŖâŖâŖ
🔗 𝐑𝐞𝐠đĸđŦ𝐭đĢ𝐚𝐭đĸ𝐨𝐧:âŖâŖ
👉 Click Here to Register: https://forms.gle/y2V26y8MofmRrSEc7âŖ
âŖâŖâŖ

Category

Telephone

Address

Dhaka
1000

Alerts

Be the first to know and let us send you an email when GenePath posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Subscribe

We will notify you when anything happens in Dhaka.